Core Insights - Persistent Systems has been recognized as a 2025 Elevate Honors recipient in the 'Growth Honor of the Year' category by Everest Group, highlighting its strong growth trajectory and commitment to long-term value creation [1][2][6] Financial Performance - The company reported $1,470.7 million in trailing twelve-month (TTM) revenue as of Q1 FY26, achieving a 25.6% compound annual growth rate (CAGR) over four years (FY21–FY25) and a 17.4% CAGR since its IPO in 2010 [2] - Persistent has delivered 21 consecutive quarters of revenue growth, showcasing sustained momentum [2] - The company has achieved a five-year shareholder return of 1,805.2%, indicating exceptional value creation for investors [2] Growth Strategy - Persistent's growth is driven by a client-centric approach, deep market understanding, and the ability to leverage emerging technologies [3] - The company has implemented an AI-led, platform-driven services strategy, with offerings such as SASVA™, iAURA, and GenAI Hub [3] - A strong partner ecosystem and a world-class global talent base further reinforce Persistent's growth [3] Recognition and Future Aspirations - The Elevate Honors recognition was announced at the Everest Group Elevate event in Dallas, focusing on enterprise growth and customer impact [4] - The CEO of Persistent expressed gratitude for the recognition, emphasizing the company's disciplined execution and innovation mindset, with aspirations to become a $5 billion company by FY31 [5] Company Overview - Persistent Systems is a global services and solutions company specializing in AI-led, platform-driven Digital Engineering and Enterprise Modernization [7] - The company employs over 25,000 individuals across 18 countries and offers a comprehensive suite of services, including software engineering, product development, data analytics, cloud computing, and intelligent automation [7] - Persistent is part of key indices such as the MSCI India Index and has achieved carbon neutrality, reflecting its commitment to sustainability [7][8]

Leaders recognition highlights Broadridge's successful accelerated strategy to invest in technology and innovation to drive business value for its BPO clients across capital markets, wealth and asset management NEW YORK , Sept. 15, 2025 /PRNewswire/ -- Broadridge Financial Solutions, Inc. (NYSE: BR), a global Fintech leader, today announced its recognition as a Leader in capital markets operations by independent research firm Everest Group in its 2025 Capital Markets Operations Services PEAK Matrix® Assessm ...

Group 1 - Everest Group, Ltd. (NYSE:EG) has launched EverBuild™, an enhanced Builder's Risk coverage form, demonstrating its commitment to the construction industry [1][2] - The new offering aims to provide clarity, flexibility, and resilience to address current construction challenges, as stated by William Hazelton, President of North America Insurance at Everest Group, Ltd. [2] - Everest Group, Ltd. operates in the reinsurance and insurance sectors, focusing on specialized and innovative solutions tailored to client needs [2]

Core Insights - Silver Scott Mines, Inc. has signed a development agreement with Everest Networks to redevelop Kanab.club into a cannabis-focused consumer social network [1] - The agreement includes the creation of the Kanab Token, aimed at enhancing user engagement and providing transactional utility on the platform [1] Company Developments - The partnership with Everest Networks signifies a strategic move towards integrating social networking and business tools specifically for the cannabis industry [1] - The redevelopment of Kanab.club is expected to cater to the needs of cannabis consumers and industry participants, potentially expanding the user base and increasing platform activity [1] Industry Implications - The introduction of the Kanab Token may facilitate transactions within the cannabis sector, promoting a more interactive and engaged community [1] - This dual-platform strategy could position the company favorably within the growing cannabis market, leveraging social networking to enhance business opportunities [1]

Group 1 - Everest Group's shares have underperformed over the past year, losing over 12% of their value [1] - The decline in share value has persisted since the company added reserves amid a management reshuffle in January [1]

Core Insights - Medidata has been recognized as a Leader in Everest Group's Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix® Assessment 2025, highlighting its success in delivering impactful solutions in the life sciences industry [1][4] - The company has maintained its leadership in the eCOA market for over a decade, with its solutions foundational to thousands of global studies across various indications [2][3] - Medidata eCOA significantly reduces study design and startup timelines, with a reduction of up to six weeks compared to the industry standard of 12 or more weeks [2] Company Achievements - Medidata's eCOA has been enhanced through a partnership with Cogstate, focusing on reducing rater burden and improving signal detection in Central Nervous System (CNS) trials [2] - The company has received consistent recognition from Everest Group in 2023 and 2024 for its Decentralized Clinical Trials, reinforcing its leadership in the clinical trial space [4] - Medidata Rave EDC and Medidata Rave CTMS have also been acknowledged, showcasing the company's commitment to improving clinical trial operations and accelerating the delivery of therapies [4] Industry Impact - Medidata has powered over 36,000 trials and 11 million patients, offering industry-leading expertise and one of the largest clinical trial data sets [6] - The company serves approximately 2,300 customers, with more than 1 million registered users relying on its end-to-end platform to enhance patient experiences and expedite clinical breakthroughs [6]

Core Insights - YPrime has been recognized as a Leader in the Everest Group's Life Sciences Electronic Clinical Outcome Assessment (eCOA) Products PEAK Matrix® Assessment 2025, highlighting its capability to deliver advanced technology and operational excellence in complex clinical trials [1][2][3] Company Achievements - The recognition as a Leader reflects YPrime's role as a trusted partner to pharmaceutical companies, biotechs, and CROs, enabling faster study launches with high-quality eCOA solutions [2][3] - YPrime was previously named a Trailblazer in Patient Engagement by Everest Group in 2024, further validating its leadership in developing patient-friendly digital tools [6] Technological Innovations - YPrime's eCOA platform is designed to scale with the complexity of global clinical trials, featuring AI-powered localization tools that automate translation processes, supporting deployments in over 250 languages across 100+ countries [3] - The Automated Data Change Form (DCF) allows site staff to execute protocol-compliant data edits in minutes, improving speed and data integrity [4] - YPrime's glucometer eCOA integration, developed with diabetes patients, enhances real-time glucose monitoring, improving patient adherence and data compliance in metabolic trials [5] Operational Excellence - YPrime's eCOA platform enhances participant compliance through an intuitive app and design, streamlining site workflows and supporting sponsors with decision-making dashboards [7]

Company Overview - Everest Group is a Delaware reinsurance company established in 1999, based in Warren, NJ, and operates as a property and casualty insurer and reinsurer across the U.S., District of Columbia, Puerto Rico, and Guam [11] - As of December 31, 2024, Everest Reinsurance reported a statutory surplus of $5.6 billion [11] - The company's strategy focuses on maintaining leadership in targeted reinsurance and insurance markets, effective management throughout the underwriting cycle, and achieving attractive returns for shareholders [11] Investment Ratings - Everest Group holds a Zacks Rank of 3 (Hold) and has a VGM Score of B, indicating a solid position in the market [12] - The company has a Value Style Score of A, supported by favorable valuation metrics such as a forward P/E ratio of 7.54, making it appealing to value investors [12] Earnings Estimates - In the last 60 days, four analysts have revised their earnings estimates for Everest Group upwards, with the Zacks Consensus Estimate increasing by $0.11 to $45.51 per share for fiscal 2025 [12] - The company has demonstrated an average earnings surprise of +3.4%, indicating a positive trend in earnings performance [12] Investment Consideration - With a strong Zacks Rank and high Value and VGM Style Scores, Everest Group is recommended for investors looking for potential opportunities in the reinsurance sector [13]

Core Viewpoint - Everest Group, Ltd. is currently experiencing a short-term bearish trend as its shares trade below the 50-day simple moving average, indicating potential resistance levels for traders and analysts [1] Price Performance - Shares of Everest Group have declined by 8.4% year-to-date, underperforming the Finance sector's growth of 10.7% and the Zacks S&P 500 Composite's growth of 9.6% [2] - The company has a market capitalization of $13.9 billion, with an average trading volume of 0.4 million shares over the last three months [2] Valuation Metrics - Everest Group's shares are trading at a price-to-book value of 0.93X, which is lower than the industry average of 2.19X, indicating that the shares are affordable [4] Growth Projections - The Zacks Consensus Estimate for Everest Group's 2025 revenues is $17.6 billion, reflecting a year-over-year growth of 2.2% [9] - The consensus estimate for current-year earnings is $45.39 per share, suggesting a significant growth of 52.2% from the previous year [9] - Projections for 2026 indicate earnings per share and revenues will increase by 34.6% and 4.8%, respectively [9] Analyst Sentiment - Analysts have recently lowered their earnings estimates for both 2025 and 2026, with a 1.2% decrease for 2025 and a 0.9% decrease for 2026 [12] Strategic Expansion - Everest Group is expanding its operations globally, reducing risk concentration in North America and enhancing diversification across over 100 countries [8][15] - The company ranks as the 4th largest P&C reinsurer, benefiting from a diversified portfolio and lower catastrophe volatility [8][16] Financial Stability - The company maintains a strong balance sheet with a debt-to-capital ratio of 19.3%, significantly below the industry average of 34.4% [18] - Its times interest earned ratio stands at 447x, far exceeding the industry's 11.5x, indicating robust financial flexibility [18] Investment Income - Net investment income is on the rise, supported by a conservative and diversified portfolio, with over 75% allocated to investment-grade fixed income [17] Shareholder Value - Everest Group has increased its dividend four times in the last five years, with a five-year annualized dividend growth rate of 11.7% [21] - The company has also approved a share buyback program worth $10 million [21] Conclusion - Everest Group benefits from strong organic growth, a conservative investment portfolio, and a solid balance sheet, which support earnings stability and risk-adjusted returns [22] - However, challenges remain due to exposure to catastrophe losses and a return on equity that lags behind the industry average [22]

Company Overview - Everest Group is a Delaware reinsurance company established in 1999, based in Warren, NJ, and operates as a property and casualty insurer and reinsurer across the U.S., District of Columbia, Puerto Rico, and Guam [12] - As of December 31, 2024, Everest Reinsurance reported a statutory surplus of $5.6 billion [12] - The company's business strategy focuses on maintaining leadership in targeted reinsurance and insurance markets, effective management throughout the underwriting cycle, and achieving attractive returns for shareholders [12] Investment Analysis - Everest Group currently holds a Zacks Rank of 3 (Hold) and has a VGM Score of B, indicating a solid position in the market [13] - The company has a Momentum Style Score of B, with shares increasing by 1.5% over the past four weeks [13] - In the last 60 days, four analysts have revised their earnings estimates higher for fiscal 2025, with the Zacks Consensus Estimate rising by $0.24 to $45.95 per share [13] - Everest Group has an average earnings surprise of +3.4%, suggesting positive performance relative to expectations [13] - Given its strong Zacks Rank and favorable Momentum and VGM Style Scores, Everest Group is recommended for investors' consideration [14]